Safety information on medicines for healthcare professionals sent in July 2008

A list of letters sent to healthcare professionals in July 2008 informing of new safety information and advice.

Date issued
Product
Safety information
 22/07/2008 Accusol 35 solution (77Kb)

Precipitate formation: caution in use needed.

See also:
Class 4 Drug Alert (Caution in Use): Baxter Healthcare Ltd - Accusol 35 Solution, Accusol 35 Potassium 2 mmol/l and Accusol 35 Potassium 4 mmol/l - EL(08)A/9

16/07/2008
Humira (adalimumab) (51Kb)

Reports of hepatosplenic T-cell lymphoma
14/07/2008 Acomplia (rimonabant) (771Kb)

Psychiatric disorders, particularly depression
14/07/2008 Avastin (bevacizumab) (315Kb) Avastin is not approved for use in combination with sunitinib for any indication
10/07/2008 Exjade (deferasirox) (35Kb) Liver failure and need for monitoring; GI haemorrhage and ulceration; and renal tubulopathy

The following information about recombinant human erythropoietins has been prepared for healthcare professionals, but has not been distributed directly to individuals:

 › Recombinant human erythropoietins and management of anaemia due to cancer (110Kb)

Page last modified: 01 August 2008